We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Britain has approved Pfizer’s COVID-19 pill for adults who have mild-to-moderate infection and are at high risk of their illness worsening, its second easily administered antiviral against the coronavirus.